Takahashi Y, Nomoto H, Yokoyama H, Takano Y, et al. Improvement of glycemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicenter, prospective, randomized, open-label, parallel-group comparison study ( Diabetes Obes Metab 2023 Feb 1. doi: 10.1111/dom.14998.
PMID: 36722623